• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/57

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

57 Cards in this Set

  • Front
  • Back
do most people die from an HIV infection?
no, they die due to a suppressed immune function and resulting infective illness
between what CD4 count is a patient at risk for Kaposi's Sarcoma
~300
between what CD4 count is a patient at risk for PCP & Herpes simplex
~200
between what CD4 count is a patient at risk for oral candidiasis
300-250
between what CD4 count is a patient at risk for herpes zoster
~350-300
between what CD4 count is a patient at risk for non-hodgkins lymphoma
250-200
between what CD4 count is a patient at risk for cryptococcus and toxoplasmosis?
150-100
between what CD4 count is a patient at risk for MAC and CMV?
100-50
when should one start/stop PRIMARY prophylaxis for PCP?

what about secondary?
PRIMARY: start CD4<200, stop CD4>200x3mo

SECONDARY: start CD4<200, stop CD4>200x3mo
when should one start/stop PRIMARY prophylaxis for toxoplasmosis?

what about secondary?
PRIMARY: start CD4<100 & IgG+ (+ serology); stop CD4>200x3mo

SECONDARY: start CD4<200; stop CD4>200x6mo
when should one start/stop PRIMARY prophylaxis for MAC?

what about secondary?
PRIMARY: start CD4<50; stop CD4>100x3mo

SECONDARY: start CD4<100; stop CD4>100x6mo
when should one start/stop PRIMARY prophylaxis for candidiasis?

what about secondary?
N/A -- no prophylaxis required, treat as pt acquires it
when should one start/stop PRIMARY prophylaxis for cryptococcus?

what about secondary?
PRIMARY: NOT recommended (consider at CD4<50) -- stop: n/a

SECONDARY: CD4<100-200; stop CD4>100-200x6mo
when should one start/stop PRIMARY prophylaxis for histoplasmosis?

what about secondary?
PRIMARY: consider start CD4<50; stop n/a

SECONDARY: life long suppressino
when should one start/stop PRIMARY prophylaxis for CMV?

what about secondary?
PRIMARY: consider start CD4<50; stop n/a

SECONDARY: consider start CD4<100-150; stop CD4>100-150x6mo
what is the clinical presentation of PCP?
pulmonary dysfunction (pneumonia)

early disease: mild sx-mild cough, exertional dyspnea, normal chest x-ray

severe disease consistent with BILATERAL pneuml: fever, nonproductive cough, SOB, diffuse pulmonary infiltrates
what is the preferred treatment regimen for PCP?
high dose bactrim (15-20mg/kg/day in 3-4 divided doses) --- 2 bactrim DS tid
what about corticosteroid use in PCP?
add on if PO2 <70mmHg

drug: methylprednisone, prednisone
if pt has a sulfa allergy, can bactrim still be used for tx of PCP? what are some s/sx of bactrim intolerance?
sulfa allergy -- do NOT use bactrim

s/sx: fever, rash, neutropenia, anemia, thrombocytopenia, hepatits, pancreatitis, interstitial nephritis
if a pt is bactrim intolerant, what are other tx options for PCP?
dont memorize - just be able to recognize that they are used SECOND line:

clindamycin + primaquine

trimethoprim + dapsone

atovaquone

pentamide
what is the preferred regimen for PCP prophylaxis? at what CD4 level should pt undergo chemoprophylaxis?
bactrim DS or SS po QD or DS TIW (less efficacious)
How is PCP diagnosed?
respiratory culture and symptoms
this disease is associated with undercooked pork, lamb, beef, transplacental spread, and ingestion of cat-derived oocysts
toxoplasmosis
toxoplsmosis is manifested via:
CNS*****: encephalitis, abcess

lung: pneumonitis

eye: retinochoroiditis
CNS manifestations in pts w/toxoplasmosis are:
fever, focal neurologic defect

ring enhancing lesions on MRI
toxoplasmosis treatment regimen
pyrimethamine + leucovorin + sulfadiazine x 3-6wks
why is leucovorin part of the treatment regimen for toxoplasmosis?
lecovorin is added to decrease pyrimethamine toxicity (its a folic acid savior)
what about maintenance therapy for toxoplasmosis? how long should the patient be on 3 drug treatment regimen?
may decrease dosage from treatment regimen for maintenance;

should be in place until CD4 count is restored (to >200x6mo)due to high relapse rate
what regimen is used for toxoplasmosis prophylaxis???
primary: bactrim DS or SS po QD

secondary: maintenance therapy with pyrimethamine+sulfadiazine+leucovorin
what should be done before beginning toxoplasmosis prophylaxis?
1. test IgG to Toxoplasma (T. gondii) to asses previous exposure -- IgG should be +
2. CD4 count should be <100

stop w/CD4>200x3mo with primary prophylaxis
What is the clinical presentation of oropharyngeal Candidiasis?
oral: creamy white patches on the tongue and other mucosal sufaces

pts may experience pn w/subsequent decrease in food and fluid intake

esophageal: painful swallowing, obstructed swallowing, sub-stemal pn

vulvovaginal: creamy, white abnormal discharge, pruritis, pn, dysuria, dyspareunia
pathogen that causes cadidiasis
Candida albicans

but there are exceptions: dubliniesis, glabrata, kruseii
how does treatment differ for mild vs. moderate to severe OPCC?
mild: topical therapy

moderate to severe, esophagitis: ALWAYS systemic therapy
what are the treatment options available for OPC?
AZOLES: fluconazole**, miconazole, itraconazole, voriconazole

POLYENES: nystatin and amphotericin B

ECHINOCANDINS: caspofungin, anidulafungin, micafungin
what is the MOA of azoles?
inhibit fungal CYP450-dependent ergosterol synthesis, resulting in impaired cell membrane integrity
what is the MOA of polyenes?
bind to ergosteral and disrupt fungal cell membrane
what is the MOA of echinocandins?
inhibit beta 1,3-glucan synthase, disrupting cell wall synthesis
what are the advantages/disadvantages of using azoles for OPC?
IV, PO formulations

fewer side effects

drug interaction potential
what are the advantages/disadvantages of using polyenes for OPC?
Nystatin is available oral or topical

amphotericin B has MANY ae's including renal dysfunction, infusion reactions, electrolyte abnormalities
what are the advantages/disadvantages of using echinocandins for OPC?
they are safe, avail on IV, and VERY expensive

*used when someone has developed resistance to azoles or poplyenes
treatment regimens for THRUSH
clotrimazole oral troches 10mg 5x/day until lesions resolve

nystatin 500,000units gargled/swich and swallow 4-5x/day

fluconazole po 100+mg/day

other options = for resistant or unresponsive OPC: itraconazole, voriconazole, oral amphotericin B, IV amphotericin

tx until symptoms resovlve (usually 7-14d)
treatment regimens for esophageal candidiasis
do NOT use topical (nystatin, clotrimazole)

Treat systemically for 14 to 21 days (Most pts respond in 5 days; Consider increasing dose or changing agent if response not seen)

Fluconazole 200mg/day and up
800mg – 1600mg may be used in certain patients

Alternative regimens:
Itraconazole, voriconazole, amphotericin B, echinocandins
is prophylaxis required for candida? if so - at what CD4 count?
Primary: Not routinely recommended

Secondary:
Consider with history of esophageal candidiasis

Fluconazole 100-200mg/day

May consider with many repeat occurrences of oral thrush

candidiasis is more frequent with CD4<100
diagnosis of candidiasis is made by doing what?
clinical exam, KOH test
this OI is caused by inhalation, then hematogenic dissmination of aerosolized organism...which is found in pigeon droppings and nesting places
Cryptococcus neoformans
S/SX of Cryptococcal neoformans
most commonly presents as meningitis** (low grade fever*, HA*, decreased cognitive function*, minimum nuchal rigidity & seizures may occur)

pulmonary disease is also possible: cough, fever, SOB, chest pn, etc.
diagnosis 101 of cryptococcal neoformans
CSF culture**, clinical symptoms, elevated CSF opening pressure (stick needle in pts back)
india ink stain**
why is it VERY important to treat cryptococcal meningitis?
it has a HIGH mortality rate!
treatment regimen for cryptococcal meningitis
Induction: Amphotericin B x 14d
(Flucystosine speeds clearance of yeast and helps prevent relapse; no initial improvement in mortality noted)


Consolidation: fluconazole 400mg/day x 8 weeks or until CSF sterile

Suppressive/maintenance: fluconazole 200mg/day
(Continue until immune reconstitution occurs with HAART)
is prophylaxis warranted for cryptococcal meningitis?
Primary: NOT routinely recommended
If done, use 100-200mg fluconazole at CD4<50

Secondary:
Lifelong UNTIL immune reconstitution
May stop with CD4≥100-200 for 6+ months, completed treatment course, and asymptomatic
this disease is caused by an organism that: Present in soil and water , domestic and farm animals, birds, foods, and some tobacco products – *we are exposed to it all the time*

Organism gains access through the gut or lungs, then spreads hematogenously
Mycobacterium avium complex

comprised of M. avium, M. intracellulare (MAI)
what organs are involved and what are the s/sx of MAC?
multiple organ involvement

s/sx - Non-specific for the most part
Weight loss, intermittent fevers, chills, night sweats, abdominal pain, diarrhea, weakness, anemia
No pulmonary symptoms*



CD4 <50 = more common than you might think
MAC = more of a dissmenated bug
tuberculosis = pulmonary dysfunction  respiratory failure
MAC = likes to get into other places in body; bone marrow, GI tract, major organs i.e. liver  severe anemia, severe GI distress (diarrhea, wasting)
Most get a bone marrow biopsy – most common diagnosis w/MAC
therapy for MAC preferred regimens:
Clarithromycin PO + ethambutol PO

Azithromycin IV/PO + ethambutol PO
therapy for severe MAC:
Use one of the preferred regimens + one of the following: (3 drugs)

Rifabutin (3rd agent), quinolone antibiotic, or amikacin
primary MAC prophylaxis: when, how?
*Primary*:
Start with CD4<50
D/C if CD4≥100 x 3+ months

Agents:
Azithromycin 1200mg qwk, clarithromycin 500mg bid, or rifabutin 300mg day

Azithromycin easiest, safest, and most widely used

Clarithromycin and rifabutin possess incr toxicity and drug interaction potential
secondary MAC prophylaxis: when, how?
Secondary:
May stop if patient’s CD4≥100 for 6+ months, has completed at least 12 months of maintenance therapy, and asymptomatic.

Agents:
Macrolide (azitho/clarithro) + ethambutol ± rifabutin
MAC diagnosis:
blood culture, bone marrow biopsy, stool culture